Latest news
Loading news…
ImmuCision Biotherapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Baltimore, Maryland, United States Founded 2017 1-10 employees For Profit
ImmuCision Biotherapeutics develops immunotherapy technologies for cancer treatment.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 8
- IT spend
- $9M
Company Info
- Founded
- 2017
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- HQ
- Baltimore, Maryland, United States
- Region
- Greater Baltimore-Maryland Area, East Coast, Southern US
Signals & Scores
- Heat score
- Medium
- Growth score
- Low
- Trend (7d)
- 1.4
- Trend (30d)
- 1.5
- Trend (90d)
- 2.1
Key People at ImmuCision Biotherapeutics
Founder and Chief Scientist
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to ImmuCision Biotherapeutics
Loading news…
FAQs about ImmuCision Biotherapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.